Scholar Rock Holding Corp (SRRK) stock
Close on Nov 11, 2026Market cap $5.68BP/E –Yield –
Scholar Rock Holding Corp reported revenue of $570.00K for the twelve months to Sep 30, 2026. Free cash flow was -$309.91M. At the latest close the market valued the company at $5.68B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.68B
- P/E ratio
- –
- Price to sales
- 9956.48
- Price to book
- 33.65
- Dividend yield
- –
- Free cash flow yield
- -5.46%
Fundamentals
- Revenue
- $570.00K
- Net income
- -$413.61M
- EPS, diluted
- -$3.23
- Free cash flow
- -$309.91M
- Book value per share
- $1.27
- Diluted shares
- 132M
Trading
- Next earnings
- Mar 2, 2027 (estimated, before the open)
- Previous close
- $48.00
- Open
- $48.09
- Day's range
- $46.47 – $48.51
- Volume
- 1,490,270
- Average volume (20 days)
- 1,733,248
- Index membership
- Russell 2000 (since Jun 2023), Russell 3000 (since Aug 2023)
- Beta (5 years)
- 1.51
- 52-week range
- $28.97 – $61.76
- RSI (14 days)
- 53.6
- Volatility (1 year)
- 57.1%
- Relative volume
- 0.97×
- WACC
- 12.2%
On 1 of our idea list: Most shorted (a warning list)
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SRRK | S&P 500 | Difference | SRRK per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.5% | -2.4% | +12.9 pts | ||
| 3 months | -10.5% | -1.2% | −9.4 pts | ||
| Year to date | +5.8% | +12.3% | −6.5 pts | ||
| 1 year | +51.3% | +12.4% | +38.9 pts | ||
| 3 years | +363.9% | +78.8% | +285.1 pts | +66.8% | +21.4% |
| 5 years | +34.8% | +75.2% | −40.4 pts | +6.1% | +11.9% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Scholar Rock filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
About Scholar Rock
Biological Products, (No Diagnostic Substances)
Scholar Rock is a biopharmaceutical company focused on discovering and developing therapies for spinal muscular atrophy and other rare neuromuscular conditions. Using a proprietary platform that targets latent growth factor precursors within tissue microenvironments, the company builds an anti-myostatin pipeline. Its lead product candidates include apitegromab, an investigational monoclonal antibody designed to inhibit myostatin activation in muscle, and SRK-439. The company develops treatments intended for pediatric and adult patients suffering from debilitating neuromuscular disorders.
Company profile, executives and historyScholar Rock stock: common questions
What is Scholar Rock's stock price?
SRRK closed at $46.60 on Nov 11, 2026, down 2.92% on the day. Over the past 52 weeks it traded between $28.97 and $61.76.
What is Scholar Rock's market cap?
Scholar Rock was worth $5.68B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SRRK's P/E ratio?
Scholar Rock lost money over the twelve months to Sep 30, 2026 (diluted EPS -$3.23), so it has no meaningful P/E ratio.
How much revenue does Scholar Rock make?
Scholar Rock reported revenue of $570.00K for the twelve months to Sep 30, 2026.
Does Scholar Rock pay a dividend?
No. Scholar Rock has not paid a cash dividend over the last twelve months.
When does Scholar Rock report earnings next?
Scholar Rock is expected to report Q4 FY2026 results on Mar 2, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has SRRK stock performed over the past year?
Including dividends, SRRK returned +51.3% over the past year, against +12.4% for the S&P 500.
How many SRRK shares are sold short?
23M shares were sold short at the latest FINRA report, 27.12% of the float, or 13.6 days of average trading volume.
Who are Scholar Rock's competitors?
Companies most similar to Scholar Rock by business, industry and size include SLDB, BIIB, TECX, JSPR, VOR.
See a number that looks wrong?